Massmedica S.A. (WSE:MSM)
Poland flag Poland · Delayed Price · Currency is PLN
6.44
+0.34 (5.57%)
At close: Feb 12, 2026

Massmedica Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
28.9732.6226.3724.8321.6118.19
Revenue Growth (YoY)
-11.86%23.71%6.21%14.89%18.78%-3.01%
Cost of Revenue
16.5219.2916.615.2712.8610.96
Gross Profit
12.4513.339.779.568.757.23
Selling, General & Admin
8.418.557.036.86.875.53
Other Operating Expenses
2.212.921.371.280.850.49
Operating Expenses
10.9211.88.678.678.16.4
Operating Income
1.521.531.10.880.650.83
Interest Expense
-0.15-0.01-0.02-0.02-0.04-0.05
Interest & Investment Income
0.010.010.030.02--
Currency Exchange Gain (Loss)
-0.08-0.08-0.02-0.02--
Other Non Operating Income (Expenses)
-0.41-0.38-0.38-0.28-0.080.01
EBT Excluding Unusual Items
0.91.070.70.580.530.79
Gain (Loss) on Sale of Assets
---0-0-0.04-0.01
Pretax Income
0.91.070.70.580.50.78
Income Tax Expense
0.220.250.190.170.150.18
Net Income
0.680.810.510.410.350.6
Net Income to Common
0.680.810.510.410.350.6
Net Income Growth
-22.81%59.11%24.52%17.83%-42.06%41.18%
Shares Outstanding (Basic)
222222
Shares Outstanding (Diluted)
222222
EPS (Basic)
0.280.340.210.170.140.25
EPS (Diluted)
0.280.340.210.170.140.25
EPS Growth
-22.81%59.11%24.52%17.83%-42.06%41.18%
Free Cash Flow
0.39-0.13-0.570.07-1.691.18
Free Cash Flow Per Share
0.16-0.06-0.230.03-0.700.49
Gross Margin
42.97%40.87%37.04%38.50%40.49%39.73%
Operating Margin
5.25%4.69%4.15%3.56%3.01%4.57%
Profit Margin
2.33%2.50%1.94%1.66%1.62%3.31%
Free Cash Flow Margin
1.33%-0.41%-2.15%0.29%-7.82%6.48%
EBITDA
1.771.861.371.471.031.21
EBITDA Margin
6.12%5.71%5.20%5.94%4.77%6.66%
D&A For EBITDA
0.250.330.280.590.380.38
EBIT
1.521.531.10.880.650.83
EBIT Margin
5.25%4.69%4.15%3.56%3.01%4.57%
Effective Tax Rate
24.47%23.82%26.71%29.20%29.57%22.55%
Revenue as Reported
---24.8321.6118.19
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.